• Research

i.a. biologic and synthetic viscosupplementing agents

Osteoarthritis symptom and disease modification

Rottapharm Biotech is developing a platform of innovative agents (undisclosed) for intra-articular (i.a.) viscosupplementation.

The platform includes, at present, both a biological product whose natural joint lubricating properties are widely described, with striking symptom- and disease-modifying activity in OA animal models, and a synthetic viscosupplement with powerful lubricating properties, widely adopted as a medical device for various uses under different forms.

Clinical trials on both assets are planned for 2018.